Variable | Model 1 | Model 2 | Model 3 |
---|---|---|---|
Coeff [95% CI] | Coeff [95% CI] | Coeff [95% CI] | |
Active lesions | |||
Endocapillary proliferation | 0.66 [− 0.12 to 1.44] | 0.64 [− 0.13 to 1.41] | 0.67 [− 0.10 to 1.43] |
Karyorrhexis | 0.93 [−2.11 to 3.97] | 0.87 [− 1.14 to 2.87] | 0.84 [− 1.16 to 2.83] |
Fibrinoid necrosis | −0.12 [− 2.82 to 2.58] | ||
Rupture of glomerular basement membranes | 2.34 [−5.52 to 10.21] | 2.26 [−4.48 to 9.00] | 2.14 [−4.60 to 8.87] |
Extracapillary proliferation | 1.79 [−0.63 to 4.22] | 1.77 [−0.62 to 4.16] | 1.84 [− 0.54 to 4.22] |
Wire loop lesions | 1.08 [0.33 to 1.82] | 1.09 [0.35 to 1.83] | 1.00 [0.28 to 1.71] |
Hyaline deposits | 1.18 [−2.65 to 5.00] | 1.12 [−2.65 to 4.89] | 1.39 [− 2.34 to 5.12] |
Membranous lesions | 0.64 [−0.07 to 1.35] | 0.67 [− 0.02 to 1.35] | 0.67 [− 0.01 to 1.36] |
Monocellular infiltration (category) | − 0.25 [− 1.48 to 0.98] | − 0.07 [− 0.53 to 0.39] | |
Chronic lesions | |||
Glomerular sclerosis | 1.13 [− 0.28 to 2.54] | 1.15 [− 0.24 to 2.54] | 1.13 [− 0.24 to 2.49] |
Fibrous adhesion | − 0.40 [− 3.41 to 2.62] | −0.35 [− 3.33 to 2.63] | −0.25 [− 3.21 to 2.71] |
Fibrous crescents | 1.63 [− 3.93 to 7.19] | 1.60 [− 3.76 to 6.95] | 1.80 [− 3.56 to 7.15] |
Interstitial fibrosis (category) | 0.23 [− 1.01 to 1.47] | 0.00 [− 0.47 to 0.47] | |
Arteriosclerosis (category) | 0.15 [− 0.38 to 0.68] | 0.13 [− 0.39 to 0.64] | 0.17 [− 0.35 to 0.68] |